MUC1-mediated motility in breast cancer: a review highlighting the role of the MUC1/ICAM-1/Src signaling triad

Clinical & Experimental Metastasis
Lacey Haddon, Judith Hugh

Abstract

Breast cancer is the most common cancer in women with the leading cause of death being metastasis, the spread of cancer to distant organs. For those patients with high-risk estrogen receptor positive (ER+) breast cancer, an increased expression of the glycoprotein MUC1 is associated with resistance to anti-hormonal therapy, metastasis and death. Tumor cells may use MUC1 to metastasize by exploiting the vascular adhesion pathways used by leukocytes during the inflammatory response. MUC1 is a type 1 transmembrane protein whose cytoplasmic tail acts as a scaffold for several signaling pathways including the non-receptor kinase Src, a signaling molecule involved in cell differentiation, proliferation, adhesion and motility. This review will highlight our current knowledge of how MUC1/ICAM-1 binding can lead to the recruitment and activation of Src and propose a novel role for lipid raft microdomains in this promigratory signaling. Improved understanding of the mechanism of metastases and the underlying signaling cascade is a prerequisite to the discovery of therapeutic targets to prevent metastasis and death in ER+ breast cancer patients.

References

Jun 15, 1994·International Journal of Cancer. Journal International Du Cancer·T SawadaY S Kim
Oct 15, 1995·European Journal of Biochemistry·I BrockhausenJ Taylor-Papadimitriou
Jul 1, 1995·Protein Science : a Publication of the Protein Society·P Bork, L Patthy
Jan 1, 1995·Annual Review of Physiology·S J Gendler, A P Spicer
Dec 20, 1995·Biochimica Et Biophysica Acta·S PattonA P Spicer
Jan 26, 1996·The Journal of Biological Chemistry·L F PembertonS J Gendler
Oct 1, 1995·Journal of Biomolecular Structure & Dynamics·J D FontenotG Gupta
Jan 1, 1996·European Biophysics Journal : EBJ·R CasadioM Compiani
Jan 1, 1997·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·K ZhangG C Hansson
Jun 5, 1997·Nature·K Simons, E Ikonen
Jan 1, 1997·Annual Review of Cell and Developmental Biology·S M Thomas, J S Brugge
Aug 30, 2000·Nature·C M PerouD Botstein
Sep 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S Etienne-MannevilleP O Couraud
Dec 19, 2000·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·R BennettA Vaheri
Feb 15, 2001·Digestion·T HayashiK Imai
Jun 8, 2001·The Journal of Biological Chemistry·C D JunT A Springer
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·C D JunT A Springer
Jun 20, 2001·Nature Reviews. Molecular Cell Biology·K Simons, D Toomre
Jul 17, 2001·Biochemical and Biophysical Research Communications·K HandaS I Hakomori
Sep 8, 2001·Journal of Mammary Gland Biology and Neoplasia·S J Gendler
Sep 8, 2001·Journal of Mammary Gland Biology and Neoplasia·J M BurchellJ Taylor-Papadimitriou
Jan 5, 2002·Experimental Cell Research·Julia C Feldner, Burkhard H Brandt
Aug 3, 2002·Nature Reviews. Molecular Cell Biology·Anthony BretscherRichard G Fehon
Feb 1, 2003·The Journal of Peptide Research : Official Journal of the American Peptide Society·J SchumanB M Longenecker
Aug 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christos SotiriouEdison T Liu
Dec 19, 2003·Nature Reviews. Cancer·Michael A Hollingsworth, Benjamin J Swanson
Apr 22, 2004·Molecular Cell·Yuting YangJia-Huai Wang
Jun 1, 2004·The Journal of Biological Chemistry·Jennifer J RahnJudith C Hugh
Oct 19, 2004·Oncogene·Sarah J Parsons, J Thomas Parsons
Oct 19, 2004·Oncogene·Titus J Boggon, Michael J Eck
Oct 19, 2004·Oncogene·Martin P Playford, Michael D Schaller
Oct 27, 2004·Biochemical and Biophysical Research Communications·Robert Roskoski

❮ Previous
Next ❯

Citations

Jul 7, 2016·Journal of breast cancer·Madalin Marius MarganMarius Raica
Aug 27, 2016·Clinical Breast Cancer·Angeles C Tecalco-Cruz, Josué O Ramírez-Jarquín
Jun 10, 2017·Expert Review of Anticancer Therapy·Parnaz MerikhianKeivan Majidzadeh-A
Dec 1, 2017·Journal of Clinical Medicine·Kosuke KatoKwang Chul Kim
May 12, 2018·Journal for Immunotherapy of Cancer·Pradip BajgainJuan F Vera
Jul 25, 2019·Scientific Reports·Xiang LiuSarah Thayer
Aug 25, 2018·Case Reports in Oncological Medicine·Frank S FanYi-Fen Wang
Aug 28, 2018·World Journal of Clinical Oncology·Angeles C Tecalco-Cruz, Josué O Ramírez-Jarquín
Jan 29, 2020·Nature Reviews. Immunology·George V SharonovDmitriy M Chudakov
Mar 8, 2020·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Xiaowen WangHua Li
Apr 6, 2021·Frontiers in Cell and Developmental Biology·Rosa VonaPaola Matarrese
Jul 3, 2021·International Journal of Molecular Sciences·Wenqing ChenKen Kin-Lam Yung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.